No evidence for metabolic syndrome and lipid profile differences in patients suffering from bipolar i disorder with and without suicide attempts

International Journal of Psychiatry in Clinical Practice

Volumn 19, Issue 3, 2015, Pages 168-173

  Ahmadpanah, Mohammad ^a   Haghighi, Mohammad ^a   Jahangard, Leila ^a   Borzoei, Shiva ^b   Heshmati, Safora ^b   Bajoghli, Hafez ^c   Holsboer Trachsler, Edith ^d   Brand, Serge ^d,e  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

acute phase; bipolar disorder; fasting blood sugar; lipid values; Metabolic syndrome; suicide

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BIPOLAR I DISORDER; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; EVIDENCE BASED PRACTICE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; ICD-10; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; MANIA; METABOLIC SYNDROME X; PRIORITY JOURNAL; SUBSTANCE ABUSE; SUICIDE ATTEMPT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BIPOLAR DISORDER; BLOOD; BLOOD PRESSURE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; BIPOLAR DISORDER; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84940976412     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2015.1049277     Document Type: Article

References (60)

1. Abreu LN, Lafer B, Baca-Garcia E, Oquendo MA. 2009. Suicidal ideation and suicide attempts in bipolar disorder type I: an update for the clinician. Revista Brasileira de Psiquiatria 31: 271-280.
2. Adibhatla RM, Hatcher JF. 2008. Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49: 241-268.
3. Adibhatla RM, Hatcher JF, Dempsey RJ. 2006. Lipids and lipidomics in brain injury and diseases. AAPS J 8: E314-E321.
4. Asellus P, Nordström P, Jokinen J. 2010. Cholesterol and CSF 5-HIAA in attempted suicide. J Affect Disord 125: 388-392.
5. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. 2008. Serum leptin and cholesterol values in violent and non-violent suicide attempters. Psychiatry Res 158: 87-91.
6. Beasley CL, Honer WG, Bergmann K, Falkai P, Lütjohann D, Bayer TA. 2005. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipol Disord 7: 449-455.
7. Beghi M, Rosenbaum JF, Cerri C, Cornaggia CM. 2013. Risk factors for fatal and nonfatal repetition of suicide attempts: a literature review. Neuropsychiatr Dis Treat 9: 1725-1736.
8. Bocchetta A, Chillotti C, Carboni G, Oi A, Ponti M, Del Zompo M. 2001. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatr Scand 104: 37-41.
9. Bolton JM, Robinson J, Sareen J. 2009. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord 115: 367-375.
10. Cardenas J, Frye MA, Marusak SL, Levander ME, Chirichigno WJ, Lewis S, et al. 2008. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord 106: 91-97.
11. Chang HH, Chou CH, Chen PS, Gean PW, Huang HC, Lin CY, et al. 2009. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord 117: 124-129.
12. Chen YW, Dilsaver SC. 1996. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry 39: 896-899.
13. Choi KH, Wang SM, Yeon B, Suh SY, Oh Y, Lee HK, et al. 2013. Risk and protective factors predicting multiple suicide attempts. Psychiatry Res 210: 957-961.
14. DAmbrosio V, Salvi V, Bogetto F, Maina G. 2012. Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 37: 136-140.
15. De Berardis D, Conti CM, Serroni N, Moschetta FS, Carano A, Salerno RM, et al. 2009. The role of cholesterol levels in mood disorders and suicide. J Biol Regul Homeost Agents 23: 133-140.
16. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Möller HJ. 2009. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24: 412-424.
17. Depner CM, Stothard ER, Wright KP Jr. 2014. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep 14: 507.
18. Diaz-Sastre C, Baca-Garcia E, Perez-Rodriguez MM, Garcia-Resa E, Ceverino A, Saiz-Ruiz J, et al. 2007. Low plasma cholesterol levels in suicidal males: a gender-and body mass index-matched case-control study of suicide attempters and nonattempters. Prog Neuro-Psychopharmacology & Biol Psychiatry 31: 901-905.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
20. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. 2005. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 7: 424-430.
21. Fiedorowicz JG, Coryell WH. 2007. Cholesterol and suicide attempts: a prospective study of depressed inpatients. Psychiatry Res 152: 11-20.
22. Garbarino S, Magnavita N. 2014. Obstructive Sleep Apnea Syndrome (OSAS), metabolic syndrome and mental health in small enterprise workers. feasibility of an action for health. PLoS One 9: e97188.
23. Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, et al. 2008. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 106: 197-201.
24. Gonda X, Pompili M, Serafini G, Montebovi F, Campi S, Dome P, et al. 2012. Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors. J Affect Disord 143: 16-26.
25. Goodrich DE, Kilbourne AM, Lai Z, Post EP, Bowersox NW, Mezuk B, et al. 2012. Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder. Contemp Clin Trials 33: 666-678.
26. Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, et al. 2007. A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. Acta Psychiatr Scand 115: 101-105.
27. John AP, Koloth R, Dragovic M, Lim SC. 2009. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust 190: 176-179.
28. Kato T. 2005. Mitochondrial dysfunction in bipolar disorder: from 31P-magnetic resonance spectroscopic findings to their molecular mechanisms. Int Rev Neurobiol 63: 21-40.
29. Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR. 2010. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 12: 404-413.
30. Kilbane EJ, Gokbayrak NS, Galynker I, Cohen L, Tross S. 2009. A review of panic and suicide in bipolar disorder: does comorbidity increase risk? J Affect Disord 115: 1-10.
31. Kim YK, Myint AM. 2004. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 81: 161-166.
32. Lala SV, Sajatovic M. 2012. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol 25: 20-25.
33. Lalovic A. 2007. The relationship between lipid metabolism and suicidal behaviour: clinical and molecular studies. Canada: McGill University.
34. Lalovic A, Levy E, Luheshi G, Canetti L, Grenier E, Sequeira A, Turecki G. 2007. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol 10: 159-166.
35. Lester D. 2002. Serum cholesterol levels and suicide: a meta-analysis. Suicide Life Threat Behav 32: 333-346.
36. Linkowski P, de Maertelaer V, Mendlewicz J. 1985. Suicidal behaviour in major depressive illness. Acta Psych Scandinavica 72: 233-238.
37. Maayan LA, Vakhrusheva J. 2010. Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment. Hum Psychopharmacol 25: 133-138.
38. Malone KM, Haas GL, Sweeney JA, Mann JJ. 1995. Major depression and the risk of attempted suicide. J Affect Disord 34: 173-185.
39. Marazziti D, Baroni S, Picchetti M, Landi P, Silvestri S, Vatteroni E, et al. 2012. Psychiatric disorders and mitochondrial dysfunctions. Eur Rev Med Pharmacol Sci 16: 270-275.
40. Marcinko D, Marcinko V, Karlović D, Marcinko A, Martinac M, Begić D, Jakovljević M. 2008. Serum lipid levels and suicidality among male patients with schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry 32: 193-196.
41. Marx CE, Stevens RD, Shampine LJ, Uzunova V, Trost WT, Butterfield MI, et al. 2006. Neuroactive steroids are altered in schizophrenia and bipolar disorder: Relevance to pathophysiology and therapeutics. Neuropsychopharmacology 31: 1249-1263.
42. McIntyre RS, Alsuwaidan M, Goldstein BI, Taylor VH, Schaffer A, Beaulieu S, Kemp DE. 2012. Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry 24: 69-81.
43. McIntyre RS, Danilewitz M, Liauw SS, Kemp DE, Nguyen HT, Kahn LS, et al. 2010. Bipolar disorder and metabolic syndrome: an international perspective. J Affect Disord 126: 366-387.
44. Neves FS, Malloy-Diniz LF, Corrêa H. 2009. Suicidal behavior in bipolar disorder: what is the influence of psychiatric comorbidities? J Clin Psych 70: 13-18.
45. Oquendo MA, Waternaux C, Brodsky B, Parsons B, Haas GL, Malone KM, Mann JJ. 2000. Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J Affect Disord 59: 107-117.
46. Roix JJ, DeCrescenzo GA, Cheung PH, Ciallella JR, Sulpice T, Saha S, Halse R. 2012. Effect of the antipsychotic agent amisulpride on glucose lowering and insulin secretion. Diabetes Obes Metab 14: 329-334.
47. Roy A. 1993. Features associated with suicide attempts in depression: a partial replication. J Affect Disord 27: 35-38.
48. Rudd MD, Goulding JM, Carlisle CJ. 2013. Stigma and suicide warning signs. Arch Suicide Res 17: 313-318.
49. Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G. 2008. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry 30: 318-323.
50. Sarchiapone M, Roy A, Camardese G, De Risio S. 2000. Further evidence for low serum cholesterol and suicidal behaviour. J Affect Disord 61: 69-71.
51. Shakeri J, Farnia V, Valinia K, Hashemian AH, Bajoghli H, Holsboer-Trachsler E, Brand S. 2015. The relationship between lifetime suicide attempts, serum lipid levels, and metabolic syndrome in patients with bipolar disorders. Int J Psych in Clin Practice 19: 124-131.
52. Shi XF, Kondo DG, Sung YH, Hellem TL, Fiedler KK, Jeong EK, et al. 2012. Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study. Bipolar Disord 14: 607-617.
53. Simon GE, Hunkeler E, Fireman B, Lee JY, Savarino J. 2007. Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord 9: 526-530.
54. Stefani KM, Kim HC, Kim J, Oh K, Suh I. 2013. The influence of sex and age on the relationship between sleep duration and metabolic syndrome in Korean adults. Diabetes Res Clin Pract 102: 250-259.
55. Suttajit S, Paholpak S, Choovanicvong S, Kittiwattanagul K, Pratoomsri W, Srisurapanont M. 2013. Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry. Neuropsychiatr Dis Treat 9: 1751-1757.
56. Valtonen HM, Suominen K, Mantere O, Leppamaki S, Arvilommi P, Isometsa E. 2007. Suicidal behaviour during different phases of bipolar disorder. J Affect Disord 97: 101-117.
57. Vuksan-Cusa B, Marcinko D, Nad S, Jakovljević M. 2009. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 33: 109-112.
58. Newcomer JW. 2007. Metabolic syndrome and mental illness. Am J Manag Care 13: 170-177.
59. Young AH, Grunze H. 2013. Physical health of patients with bipolar disorder. Acta Psychiatr Scand Suppl 442: 3-10.
60. Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E, et al. 2007. Atypical antipsychotic related metabolic syndrome in bipolar patients. J Affect Disord 98: 247-252.